Hi @Tarvold as much as current holders hate to hear it you make...

Hi @Tarvold as much as current holders hate to hear it you make some very valid points. The reality is no one believes what Zoono says anymore with the rubbish that was announced in the past that all fell through. i.e. 7/11 which PH explained in the last webinar. Zoono were happy to announce trials but never gave an update without being asked. The explanation sounded truthful regarding 7/11 leading them on however there was no initiative to provide an update from management. Now if the same thing happens with Microsoft it would be very concerning. From publicly available news Microsoft are cautious about reopening offices. This will lead to delays and possibly cancellations. If someone in HC who is in frequent communication with PH or management can confirm, that would be great along with the suggestion for the newsletter to include update on previously announced trials etc. The newsletter currently appears to be a way to appease the shareholders and build hype without providing proper insights and updates.

I will be looking very closely at the next quarterly. Anything less than 7mil will set off alarm bells, I suspect any cash receipts from recent growth will not be seen until Q2. I think all holders need to balance the good with the bad. So far there has been a lot more bad than good. The product is effective it so maybe it is the price point that is the issue. We also need to remember that Zoono are up against some large incumbents who will not be happy losing market share.